434 related articles for article (PubMed ID: 26150605)
1. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
Cornec-Le Gall E; Audrézet MP; Rousseau A; Hourmant M; Renaudineau E; Charasse C; Morin MP; Moal MC; Dantal J; Wehbe B; Perrichot R; Frouget T; Vigneau C; Potier J; Jousset P; Guillodo MP; Siohan P; Terki N; Sawadogo T; Legrand D; Menoyo-Calonge V; Benarbia S; Besnier D; Longuet H; Férec C; Le Meur Y
J Am Soc Nephrol; 2016 Mar; 27(3):942-51. PubMed ID: 26150605
[TBL] [Abstract][Full Text] [Related]
2. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
3. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
Cornec-Le Gall E; Blais JD; Irazabal MV; Devuyst O; Gansevoort RT; Perrone RD; Chapman AB; Czerwiec FS; Ouyang J; Heyer CM; Senum SR; Le Meur Y; Torres VE; Harris PC
Nephrol Dial Transplant; 2018 Apr; 33(4):645-652. PubMed ID: 28992127
[TBL] [Abstract][Full Text] [Related]
4. Type of PKD1 mutation influences renal outcome in ADPKD.
Cornec-Le Gall E; Audrézet MP; Chen JM; Hourmant M; Morin MP; Perrichot R; Charasse C; Whebe B; Renaudineau E; Jousset P; Guillodo MP; Grall-Jezequel A; Saliou P; Férec C; Le Meur Y
J Am Soc Nephrol; 2013 May; 24(6):1006-13. PubMed ID: 23431072
[TBL] [Abstract][Full Text] [Related]
5. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
Magistroni R; He N; Wang K; Andrew R; Johnson A; Gabow P; Dicks E; Parfrey P; Torra R; San-Millan JL; Coto E; Van Dijk M; Breuning M; Peters D; Bogdanova N; Ligabue G; Albertazzi A; Hateboer N; Demetriou K; Pierides A; Deltas C; St George-Hyslop P; Ravine D; Pei Y
J Am Soc Nephrol; 2003 May; 14(5):1164-74. PubMed ID: 12707387
[TBL] [Abstract][Full Text] [Related]
6. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
[TBL] [Abstract][Full Text] [Related]
7. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
[TBL] [Abstract][Full Text] [Related]
8. Family history of renal disease severity predicts the mutated gene in ADPKD.
Barua M; Cil O; Paterson AD; Wang K; He N; Dicks E; Parfrey P; Pei Y
J Am Soc Nephrol; 2009 Aug; 20(8):1833-8. PubMed ID: 19443633
[TBL] [Abstract][Full Text] [Related]
9. Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
.
Nowak KL; Chonchol M; You Z; Gupta M; Gitomer B
Clin Nephrol; 2018 Mar; 89(3):196-204. PubMed ID: 29035198
[TBL] [Abstract][Full Text] [Related]
10. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing.
Kim H; Park HC; Ryu H; Kim H; Lee HS; Heo J; Lee C; Kim NKD; Park WY; Hwang YH; Lee KB; Oh KH; Oh YK; Ahn C
Sci Rep; 2019 Nov; 9(1):16952. PubMed ID: 31740684
[TBL] [Abstract][Full Text] [Related]
11. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.
Ali H; Alahmad B; Senum SR; Warsame S; Bahbahani Y; Abu-Farha M; Abubaker J; Alqaddoumi M; Al-Mulla F; Harris PC
Am J Nephrol; 2024; 55(3):380-388. PubMed ID: 38194940
[TBL] [Abstract][Full Text] [Related]
12. Combining genotype with height-adjusted kidney length predicts rapid progression of ADPKD.
Chen EWC; Chong J; Valluru MK; Durkie M; Simms RJ; Harris PC; Ong ACM
Nephrol Dial Transplant; 2024 May; 39(6):956-966. PubMed ID: 38224954
[TBL] [Abstract][Full Text] [Related]
13. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
[TBL] [Abstract][Full Text] [Related]
14. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
[TBL] [Abstract][Full Text] [Related]
15. Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study.
Ushio Y; Kataoka H; Sato M; Manabe S; Watanabe S; Akihisa T; Makabe S; Yoshida R; Tsuchiya K; Nitta K; Mochizuki T
Clin Exp Nephrol; 2020 Jun; 24(6):500-508. PubMed ID: 32036465
[TBL] [Abstract][Full Text] [Related]
16. Variation in age at ESRD in autosomal dominant polycystic kidney disease.
Reed BY; McFann K; Bekheirnia MR; Nobakhthaghighi N; Masoumi A; Johnson AM; Shamshirsaz AA; Kelleher CL; Schrier RW
Am J Kidney Dis; 2008 Feb; 51(2):173-83. PubMed ID: 18215695
[TBL] [Abstract][Full Text] [Related]
17. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
Grau L; Gitomer B; McNair B; Wolf M; Harris P; Brosnahan G; Torres V; Steinman T; Yu A; Chapman A; Chonchol M; Nowak KL
Kidney360; 2020 Jul; 1(7):648-656. PubMed ID: 33305291
[TBL] [Abstract][Full Text] [Related]
18. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.
Higashihara E; Horie S; Kinoshita M; Harris PC; Okegawa T; Tanbo M; Hara H; Yamaguchi T; Shigemori K; Kawano H; Miyazaki I; Kaname S; Nutahara K
Clin Exp Nephrol; 2018 Apr; 22(2):395-404. PubMed ID: 28983800
[TBL] [Abstract][Full Text] [Related]
19. Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.
Higashihara E; Horie S; Muto S; Kawano H; Tambo M; Yamaguchi T; Taguchi S; Kaname S; Yokoyama K; Yoshioka T; Furukawa T; Fukuhara H
Am J Nephrol; 2020; 51(11):881-890. PubMed ID: 33227802
[TBL] [Abstract][Full Text] [Related]
20. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
